Cover Page
Cover Page - shares | 9 Months Ended | |
Dec. 31, 2022 | Feb. 03, 2023 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Dec. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-38021 | |
Entity Registrant Name | HAMILTON LANE INC | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 26-2482738 | |
Entity Address, Address Line One | 110 Washington Street, | |
Entity Address, Address Line Two | Suite 1300 | |
Entity Address, City or Town | Conshohocken, | |
Entity Address, State or Province | PA | |
Entity Address, Postal Zip Code | 19428 | |
City Area Code | 610 | |
Local Phone Number | 934-2222 | |
Title of 12(b) Security | Class A Common Stock, $0.001 par value per share | |
Trading Symbol | HLNE | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Emerging Growth Company | false | |
Entity Small Business | false | |
Entity Shell Company | false | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Entity Central Index Key | 0001433642 | |
Current Fiscal Year End Date | --03-31 | |
Class A Common Stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding (in shares) | 37,868,486 | |
Class B Common Stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding (in shares) | 15,948,744 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) | Dec. 31, 2022 | Mar. 31, 2022 |
Assets | ||
Fees receivable | $ 52,074,000 | $ 51,869,000 |
Prepaid expenses | 7,078,000 | 6,858,000 |
Due from related parties | 7,784,000 | 1,872,000 |
Furniture, fixtures and equipment, net | 28,348,000 | 28,842,000 |
Lease right-of-use assets, net | 63,152,000 | 65,636,000 |
Investments | 514,332,000 | 503,789,000 |
Deferred income taxes | 230,154,000 | 245,046,000 |
Assets of consolidated variable interest entities: | ||
Investments | 514,332,000 | 503,789,000 |
Total assets | 1,124,361,000 | 1,294,946,000 |
Liabilities, redeemable non-controlling interests and equity | ||
Accounts payable | 2,045,000 | 2,827,000 |
Accrued compensation and benefits | 65,761,000 | 20,117,000 |
Accrued members’ distributions | 19,161,000 | 27,119,000 |
Accrued dividend | 14,810,000 | 12,947,000 |
Debt | 199,126,000 | 171,326,000 |
Payable to related parties pursuant to tax receivable agreement | 179,431,000 | 180,536,000 |
Lease liabilities | 79,549,000 | 82,244,000 |
Liabilities of consolidated variable interest entities: | ||
Total liabilities | 594,403,000 | 557,460,000 |
Commitments and contingencies (Note 16) | ||
Redeemable non-controlling interests | 0 | 276,000,000 |
Preferred stock, $0.001 par value, 10,000,000 authorized, none issued | 0 | 0 |
Additional paid-in-capital | 166,821,000 | 161,676,000 |
Total Hamilton Lane Incorporated stockholders’ equity | 394,661,000 | 346,878,000 |
Total equity | 529,958,000 | 461,486,000 |
Total liabilities, redeemable non-controlling interests and equity | 1,124,361,000 | 1,294,946,000 |
Class A Common Stock | ||
Liabilities of consolidated variable interest entities: | ||
Common stock | 38,000 | 37,000 |
Class B Common Stock | ||
Liabilities of consolidated variable interest entities: | ||
Common stock | 16,000 | 16,000 |
Consolidated Entity Excluding Variable Interest Entities (VIE) | ||
Assets | ||
Cash and cash equivalents | 146,070,000 | 72,138,000 |
Restricted cash | 3,116,000 | 4,023,000 |
Investments | 514,332,000 | 503,789,000 |
Other assets | 30,755,000 | 28,162,000 |
Assets of consolidated variable interest entities: | ||
Cash and cash equivalents | 146,070,000 | 72,138,000 |
Investments held in trust | 3,116,000 | 4,023,000 |
Investments | 514,332,000 | 503,789,000 |
Other assets | 30,755,000 | 28,162,000 |
Liabilities, redeemable non-controlling interests and equity | ||
Other liabilities (includes $13,954 and $13,818 at fair value) | 34,503,000 | 47,669,000 |
Liabilities of consolidated variable interest entities: | ||
Other liabilities | 34,503,000 | 47,669,000 |
Primary Beneficiary | ||
Assets | ||
Cash and cash equivalents | 3,909,000 | 36,000 |
Restricted cash | 0 | 276,016,000 |
Investments | 37,360,000 | 10,036,000 |
Other assets | 229,000 | 623,000 |
Assets of consolidated variable interest entities: | ||
Cash and cash equivalents | 3,909,000 | 36,000 |
Investments held in trust | 0 | 276,016,000 |
Investments | 37,360,000 | 10,036,000 |
Other assets | 229,000 | 623,000 |
Liabilities, redeemable non-controlling interests and equity | ||
Other liabilities (includes $13,954 and $13,818 at fair value) | 17,000 | 12,675,000 |
Liabilities of consolidated variable interest entities: | ||
Other liabilities | 17,000 | 12,675,000 |
Total liabilities | 0 | 0 |
General Partnerships | ||
Liabilities of consolidated variable interest entities: | ||
Stockholders' equity attributable to noncontrolling interest | 3,653,000 | 3,423,000 |
Hamilton Lane Advisors, L.L.C. | ||
Liabilities of consolidated variable interest entities: | ||
Retained earnings | 227,786,000 | 185,149,000 |
Stockholders' equity attributable to noncontrolling interest | $ 131,644,000 | $ 111,185,000 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Class of Stock [Line Items] | ||
Other liabilities, fair value | $ 13,954 | $ 13,818 |
Preferred stock, par value (in USD per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Class A Common Stock | ||
Class of Stock [Line Items] | ||
Common stock, par value (in USD per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 300,000,000 | 300,000,000 |
Common stock, shares issued (in shares) | 37,868,691 | 37,280,697 |
Common stock, shares outstanding (in shares) | 37,868,691 | 37,280,697 |
Class B Common Stock | ||
Class of Stock [Line Items] | ||
Common stock, par value (in USD per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 50,000,000 | 50,000,000 |
Common stock, shares issued (in shares) | 15,953,682 | 16,033,359 |
Common stock, shares outstanding (in shares) | 15,953,682 | 16,033,359 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues | ||||
Total revenues | $ 127,074 | $ 91,704 | $ 415,965 | $ 267,019 |
Consolidated variable interest entities related: | ||||
Total revenues | 127,074 | 91,704 | 415,965 | 267,019 |
Expenses | ||||
Compensation and benefits | 45,676 | 34,004 | 158,235 | 94,028 |
Consolidated variable interest entities related: | ||||
Total expenses | 68,702 | 50,658 | 225,242 | 143,722 |
Other income (expense) | ||||
Equity in income (loss) of investees | 650 | 12,924 | (7,493) | 60,181 |
Interest income | 442 | 26 | 839 | 488 |
Non-operating (expense) income | (27,960) | 37,043 | (11,878) | 65,500 |
Consolidated variable interest entities related: | ||||
Unrealized income | 18,578 | 47,774 | ||
Total other income (expense) | (24,700) | 50,669 | (16,207) | 123,914 |
Income before income taxes | 33,672 | 91,715 | 174,516 | 247,211 |
Income tax expense | 11,788 | 11,519 | 38,766 | 37,515 |
Net income | 21,884 | 80,196 | 135,750 | 209,696 |
Net income attributable to Hamilton Lane Incorporated | 9,669 | 51,849 | 78,034 | 132,161 |
Class A Common Stock | ||||
Consolidated variable interest entities related: | ||||
Net income attributable to Hamilton Lane Incorporated | $ 9,669 | $ 51,849 | $ 78,034 | $ 132,161 |
Basic earnings per share of Class A common stock (in dollars per share) | $ 0.32 | $ 1.44 | $ 2.21 | $ 3.64 |
Diluted earnings per share of Class A common stock (in dollars per share) | 0.31 | 1.40 | 2.19 | 3.59 |
Dividends declared per share of Class A common stock (in dollars per share) | $ 0.40 | $ 0.35 | $ 1.20 | $ 1.05 |
Consolidated Entity Excluding Variable Interest Entities (VIE) | ||||
Expenses | ||||
General, administrative and other | $ 22,717 | $ 16,332 | $ 66,066 | $ 48,742 |
Consolidated variable interest entities related: | ||||
General, administrative and other | 22,717 | 16,332 | 66,066 | 48,742 |
Other income (expense) | ||||
Interest expense | (2,419) | (1,157) | (6,027) | (3,488) |
Primary Beneficiary | ||||
Expenses | ||||
General, administrative and other | 309 | 322 | 941 | 952 |
Consolidated variable interest entities related: | ||||
General, administrative and other | 309 | 322 | 941 | 952 |
Other income (expense) | ||||
Interest expense | 0 | (4) | 0 | (4) |
Interest income | 2,111 | 0 | 2,989 | 0 |
Consolidated variable interest entities related: | ||||
Equity in income (loss) of investees | 389 | (298) | 1,030 | 170 |
Unrealized income | 2,087 | 2,135 | 4,333 | 1,067 |
General Partnerships | ||||
Consolidated variable interest entities related: | ||||
Less: (loss) Income attributable to non-controlling interests | 422 | (119) | 773 | 167 |
Hamilton Lane Advisors, L.L.C. | ||||
Consolidated variable interest entities related: | ||||
Less: (loss) Income attributable to non-controlling interests | 9,146 | 26,181 | 51,326 | 76,849 |
Hamilton Lane Alliance Holdings I, Inc. | ||||
Consolidated variable interest entities related: | ||||
Less: (loss) Income attributable to non-controlling interests | 2,647 | 2,285 | 5,617 | 519 |
Management and advisory fees | ||||
Revenues | ||||
Total revenues | 97,355 | 79,836 | 276,182 | 229,653 |
Consolidated variable interest entities related: | ||||
Total revenues | 97,355 | 79,836 | 276,182 | 229,653 |
Incentive fees | ||||
Revenues | ||||
Total revenues | 29,719 | 11,868 | 139,783 | 37,366 |
Consolidated variable interest entities related: | ||||
Total revenues | 29,719 | 11,868 | 139,783 | 37,366 |
Incentive fees | Consolidated Entity Excluding Variable Interest Entities (VIE) | ||||
Revenues | ||||
Total revenues | 24,075 | 10,490 | 132,835 | 34,217 |
Consolidated variable interest entities related: | ||||
Total revenues | 24,075 | 10,490 | 132,835 | 34,217 |
Incentive fees | Primary Beneficiary | ||||
Revenues | ||||
Total revenues | 5,644 | 1,378 | 6,948 | 3,149 |
Consolidated variable interest entities related: | ||||
Total revenues | $ 5,644 | $ 1,378 | $ 6,948 | $ 3,149 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands | Total | Common Stock Class A Common Stock | Common Stock Class B Common Stock | Additional Paid in Capital | Retained Earnings | General Partnerships Noncontrolling Interests | Hamilton Lane Advisors, L.L.C. Noncontrolling Interests |
Beginning balance at Mar. 31, 2021 | $ 314,201 | $ 36 | $ 17 | $ 150,564 | $ 87,512 | $ 2,211 | $ 73,861 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 209,177 | 132,161 | 167 | 76,849 | |||
Equity-based compensation | 5,706 | 3,870 | 1,836 | ||||
Repurchase of Class A shares for employee tax withholding | (605) | (220) | (385) | ||||
Deferred tax adjustment | 2,722 | 2,722 | |||||
Dividends declared | (38,429) | (38,429) | |||||
Capital contributions from non-controlling interests, net | 563 | 563 | |||||
Member distributions | (32,361) | (32,361) | |||||
Secondary offerings | (1) | 1 | (1) | 4,097 | (4,098) | ||
Employee Share Purchase Plan share issuance | 1,382 | 936 | 446 | ||||
Adjustment of redeemable non-controlling interest to redemption value | 520 | 393 | 127 | ||||
Equity reallocation between controlling and non-controlling interests | 0 | 98 | (98) | ||||
Ending balance at Dec. 31, 2021 | 462,875 | 37 | 16 | 162,067 | 181,637 | 2,941 | 116,177 |
Beginning balance at Sep. 30, 2021 | 404,252 | 37 | 16 | 161,000 | 141,130 | 2,904 | 99,165 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 77,911 | 51,849 | (119) | 26,181 | |||
Equity-based compensation | 1,711 | 1,179 | 532 | ||||
Repurchase of Class A shares for employee tax withholding | 0 | ||||||
Deferred tax adjustment | 2 | 2 | 0 | ||||
Dividends declared | (12,916) | (12,916) | |||||
Capital contributions from non-controlling interests, net | 156 | 156 | |||||
Member distributions | (11,024) | (11,024) | |||||
Secondary offerings | 0 | 0 | 0 | 0 | |||
Employee Share Purchase Plan share issuance | 498 | 340 | 158 | ||||
Adjustment of redeemable non-controlling interest to redemption value | 2,285 | 0 | 1,574 | 711 | |||
Equity reallocation between controlling and non-controlling interests | 0 | (454) | 454 | ||||
Ending balance at Dec. 31, 2021 | 462,875 | 37 | 16 | 162,067 | 181,637 | 2,941 | 116,177 |
Beginning balance at Mar. 31, 2022 | 461,486 | 37 | 16 | 161,676 | 185,149 | 3,423 | 111,185 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 130,133 | 78,034 | 773 | 51,326 | |||
Equity-based compensation | 6,816 | 4,702 | 2,114 | ||||
Repurchase of Class A shares for employee tax withholding | (162) | (112) | (50) | ||||
Dividends declared | (44,413) | (44,413) | |||||
Capital contributions to non-controlling interests, net | (543) | (543) | |||||
Member distributions | (37,871) | (37,871) | |||||
Employee Share Purchase Plan share issuance | 1,441 | 1 | 993 | 447 | |||
Adjustment of redeemable non-controlling interest to redemption value | 13,071 | 9,016 | 4,055 | ||||
Equity reallocation between controlling and non-controlling interests | 0 | (438) | 438 | ||||
Ending balance at Dec. 31, 2022 | 529,958 | 38 | 16 | 166,821 | 227,786 | 3,653 | 131,644 |
Beginning balance at Sep. 30, 2022 | 524,978 | 38 | 16 | 164,763 | 225,957 | 3,820 | 130,384 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 19,237 | 9,669 | 422 | 9,146 | |||
Equity-based compensation | 2,835 | 1,956 | 879 | ||||
Repurchase of Class A shares for employee tax withholding | (70) | (48) | (22) | ||||
Dividends declared | (14,810) | (14,810) | |||||
Capital contributions to non-controlling interests, net | (589) | (589) | |||||
Member distributions | (12,164) | (12,164) | |||||
Employee Share Purchase Plan share issuance | 439 | 0 | 303 | 136 | |||
Adjustment of redeemable non-controlling interest to redemption value | 10,102 | 6,970 | 3,132 | ||||
Equity reallocation between controlling and non-controlling interests | 0 | (153) | 153 | ||||
Ending balance at Dec. 31, 2022 | $ 529,958 | $ 38 | $ 16 | $ 166,821 | $ 227,786 | $ 3,653 | $ 131,644 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 9 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Operating activities: | ||
Net income | $ 135,750 | $ 209,696 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 5,600 | 3,744 |
Change in deferred income taxes | 14,892 | 19,941 |
Change in payable to related parties pursuant to tax receivable agreement | (1,105) | (6,202) |
Equity-based compensation | 6,816 | 5,706 |
Equity in loss (income) of investees | 7,493 | (60,181) |
Gain on sale of investment | (9,783) | (11,936) |
Fair value adjustment of other investments | (18,578) | (47,774) |
Proceeds received from partnerships | 11,877 | 38,945 |
Non-cash lease expense | 5,370 | 7,210 |
Gain on sale of intangible asset | 2,771 | 0 |
Impairment of other investment | 43,289 | 0 |
Other | (2,864) | 43 |
Changes in operating assets and liabilities: | ||
Fees receivable | (205) | (17,883) |
Prepaid expenses | (220) | 263 |
Due from related parties | (5,911) | 479 |
Other assets | (5,309) | 256 |
Accounts payable | (782) | 17 |
Accrued compensation and benefits | 45,644 | 18,867 |
Lease liability | (5,581) | (1,410) |
Other liabilities | (11,548) | (6,457) |
Consolidated variable interest entities related: | ||
Net cash provided by operating activities | 213,371 | 152,512 |
Investing activities: | ||
Purchase of furniture, fixtures and equipment | (3,261) | (7,788) |
Cash paid for acquisition of business | (1,500) | (10,096) |
Loans to investees | (2,535) | 0 |
Purchase of other investments | (34,125) | (18,798) |
Proceeds from sale of investments | 10,000 | 12,623 |
Distributions from investments | 1,406 | 12,739 |
Distributions received from Partnerships | 15,990 | 12,088 |
Contributions to Partnerships | (63,364) | (56,432) |
Sale of investments held in trust | 278,954 | 0 |
Net cash provided by (used in) investing activities | 201,565 | (55,664) |
Financing activities: | ||
Proceeds from offerings | 0 | 73,833 |
Purchase of membership interests | 0 | (73,833) |
Borrowings of debt | 31,682 | 0 |
Repayments of debt | (3,873) | (1,382) |
Draw-down on revolver | 25,000 | 0 |
Repayment of revolver | (25,000) | (15,000) |
Repurchase of Class A shares for employee tax withholding | (162) | (605) |
Proceeds received from issuance of shares under Employee Share Purchase Plan | 1,441 | 1,382 |
Payments to related parties, pursuant to tax receivable agreement | 0 | (15,584) |
Dividends paid | (42,550) | (36,714) |
Members’ distributions paid | (45,828) | (37,469) |
Other | 0 | (75) |
Consolidated variable interest entities related: | ||
Net cash used in financing activities | (338,038) | (104,885) |
Increase (decrease) in cash, cash equivalents, and restricted cash | 76,898 | (8,037) |
Cash, cash equivalents, and restricted cash at beginning of the period | 76,197 | 90,377 |
Cash and cash equivalents, restricted cash, and cash and cash equivalents held at consolidated variable interest entities at end of the period | 153,095 | 82,340 |
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets: | ||
Total cash and cash equivalents, restricted cash, and cash and cash equivalents held at consolidated variable interest entities | 153,095 | 82,340 |
Class B Common Stock | ||
Financing activities: | ||
Repurchase of common stock | 0 | (1) |
Consolidated Entity Excluding Variable Interest Entities (VIE) | ||
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets: | ||
Cash and cash equivalents | 146,070 | 78,838 |
Restricted cash | 3,116 | 3,315 |
Primary Beneficiary | ||
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Fair value adjustment of other investments | (4,333) | (1,067) |
Consolidated variable interest entities related: | ||
Change in warrant liability measured at fair value | (2,883) | (1,067) |
Equity in income of investees | (1,030) | (170) |
Other assets and liabilities | (332) | 425 |
Consolidated variable interest entities related: | ||
Contributions from non-controlling interest in general partnerships | 687 | 1,053 |
Distributions to non-controlling interest in general partnerships | (1,230) | (490) |
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets: | ||
Cash and cash equivalents | 3,909 | 187 |
Restricted cash | 0 | |
Primary Beneficiary | Class A Common Stock | ||
Financing activities: | ||
Repurchase of common stock | $ (278,205) | $ 0 |
Organization
Organization | 9 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | 1. Organization Hamilton Lane Incorporated (“HLI”) is a holding company whose principal asset is a controlling equity interest in Hamilton Lane Advisors, L.L.C. (“HLA”). As the sole managing member of HLA, HLI operates and controls all of the business and affairs of HLA, and through HLA, conducts its business. As a result, HLI consolidates HLA’s financial results and reports a non-controlling interest related to the portion of HLA units not owned by HLI. The assets and liabilities of HLA represent substantially all of HLI’s consolidated assets and liabilities with the exception of certain cash, certain deferred tax assets and liabilities, payable to related parties pursuant to a tax receivable agreement, and dividends payable. Unless otherwise specified, “the Company” refers to the consolidated entity of HLI, HLA and subsidiaries throughout the remainder of these notes. As of December 31, 2022 and March 31, 2022, HLI held approximately 69.0% and 68.9%, respectively, of the economic interest in HLA. As future exchanges of HLA units occur pursuant to the exchange agreement in place with HLA’s members, the economic interest in HLA held by HLI will increase. HLA is a registered investment advisor with the United States Securities and Exchange Commission (“SEC”), providing asset management and advisory services, primarily to institutional investors, to design, build and manage private markets portfolios. HLA generates revenues primarily from management fees, by managing assets on behalf of customized separate accounts, specialized fund products and distribution management accounts, and advisory fees, by providing asset supervisory and reporting services. HLA sponsors the formation, and serves as the general partner or managing member, of various limited liability partnerships consisting of specialized funds and certain single client separate account entities (“Partnerships”) that acquire interests in third-party managed investment funds that make private equity and equity-related investments. The Partnerships may also make direct investments, including investments in debt, equity, and other equity-based instruments. The Company, which includes certain subsidiaries that serve as the general partner or managing member of the Partnerships, may invest its own capital in the Partnerships and generally makes all investment and operating decisions for the Partnerships. HLA operates several wholly-owned entities through which it conducts its foreign operations. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. Management believes it has made all necessary adjustments (which consisted of only normal recurring items) so that the condensed consolidated financial statements are presented fairly and that estimates made in preparing the condensed consolidated financial statements are reasonable and prudent. Results of operations for the three and nine months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the year ending March 31, 2023. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in HLI’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022. Accounting for Differing Fiscal Periods The Partnerships primarily have a fiscal year end as of December 31, and the Company accounts for its investments in the Partnerships using a three-month lag due to the timing of financial information received from the investments held by the Partnerships. The Partnerships primarily invest in private equity funds, which generally require at least 90 days following the calendar year end to present audited financial statements. The Company records its share of capital contributions to and distributions from the Partnerships in investments in the Condensed Consolidated Balance Sheets during the three-month lag period. Fair Value of Financial Instruments The Company utilizes a hierarchy that prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach, and cost approach). The levels of the hierarchy are described below: • Level 1: Values are determined using quoted market prices for identical financial instruments in an active market. • Level 2: Values are determined using quoted prices for similar financial instruments and valuation models whose inputs are observable. • Level 3: V alues are determined using pricing models that use significant inputs that are primarily unobservable, discounted cash flow methodologies or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. The carrying amount of cash and cash equivalents, fees receivable, and accounts payable approximate fair value due to the immediate or short-term maturity of these financial instruments. Recent Accounting Pronouncements In June 2022, the Financial Accounting Standards Board issued Accounting Standard Update ("ASU") 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this update clarify the guidance in Topic 820 when measuring the fair value of an equity security subject to contractual sale restrictions and introduce new disclosure requirements related to such equity securities. The amendments are effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its condensed consolidated financial statements. Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. |
Revenue
Revenue | 9 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | 3. Revenue The following table presents revenues disaggregated by product offering, which aligns with the identified performance obligations and the basis for calculating each amount: Three Months Ended Nine Months Ended December 31, Management and advisory fees 2022 2021 2022 2021 Specialized funds $ 53,299 $ 38,233 $ 144,099 $ 107,935 Customized separate accounts 29,571 25,982 87,329 75,416 Advisory 6,613 6,119 19,073 18,781 Reporting and other 6,720 5,992 19,170 16,983 Distribution management 596 3,170 1,863 9,313 Fund reimbursement revenue 556 340 4,648 1,225 Total management and advisory fees $ 97,355 $ 79,836 $ 276,182 $ 229,653 Three Months Ended Nine Months Ended December 31, Incentive fees 2022 2021 2022 2021 Specialized funds $ 8,679 $ 6,765 $ 102,815 $ 23,903 Customized separate accounts 15,396 3,725 30,020 10,314 Consolidated variable interest related: Specialized funds 5,644 1,378 6,948 3,149 Total incentive fees $ 29,719 $ 11,868 $ 139,783 $ 37,366 |
Investments
Investments | 9 Months Ended |
Dec. 31, 2022 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Investments | 4. Investments Investments consist of the following: December 31, March 31, 2022 2022 Equity method investments in Partnerships $ 328,311 $ 326,296 Other equity method investments — 1,573 Other investments 20,189 19,820 Investments valued under the measurement alternative 165,832 156,100 Total Investments $ 514,332 $ 503,789 Equity method investments The Company’s equity method investments in Partnerships represent its ownership in certain specialized funds and customized separate accounts. The strategies and geographic location of investments within the Partnerships vary by fund. The Company has a 1% interest in substantially all of the Partnerships. During the quarter ended September 30, 2022, the Company sold its ownership interests in its joint venture that automates the collection of fund and underlying portfolio company data from general partners, Private Markets Connect, for $10,000 and recognized a gain of $9,783 which is recorded in non-operating (expense) income in the Condensed Consolidated Statements of Income. Immediately preceding the sale, the Company received a distribution from the joint venture of $1,406. Other investments The Company’s other investments represent a publicly traded security and investments in private equity funds and direct credit and equity investments that are held as collateral on the Company’s secured financing. The private equity fund investments can only be redeemed through distributions received from the liquidation of underlying investments of the fund, and the timing of distributions is currently indeterminable. The direct credit investments are debt securities classified as trading securities. Other investments are measured at fair value with unrealized holding gains and losses recorded in non-operating (expense) income in the Condensed Consolidated Statements of Income. The Company accounts for its secured financing at fair value under the fair value option. The primary reason for electing the fair value option is to mitigate volatility in earnings from using different measurement attributes. The significant input to the fair value of the secured financing is the fair value of the other investments delivered as collateral which are estimated using Level 3 inputs with the significant inputs as shown in Note 5 below. The Company recognized a gain on other investments held as collateral of $821 and $915 during the three and nine months ended December 31, 2022, respectively, and a gain of $2,288 and $3,239 during the three and nine months ended December 31, 2021, respectively, that are recorded in non-operating (expense) income. The Company recognized a loss on the secured financing liability of $821 and $915 during the three and nine months ended December 31, 2022, respectively, and a loss of $2,288 and $3,239 during the three and nine months ended December 31, 2021, respectively, that are recorded in non-operating (expense) income in the Condensed Consolidated Statements of Income. Investments valued under the measurement alternative During the quarter ended June 30, 2022, the Company made investments in two private companies. The Company invested $3,000 in a technology driven platform that provides a digitized token for investors that improves the efficiency of capital raises. Additionally, the Company invested $12,000 in an online financial services platform. Due to the lack of readily determinable fair values for these investments, over which the Company does not have significant influence, the Company values the investments under the measurement alternative. During the quarter ended June 30, 2022, the Company made an additional investment of $5,236 in a company that maintains a platform of solutions designed to aid individual investors and various wealth management platforms with their wealth management needs. As a result of the transaction, the Company marked its original investment to fair value based upon the transaction price, which resulted in total unrealized gain of $6,687 during the three months ended June 30, 2022, that is recorded in non-operating (expense) income in the Condensed Consolidated Statements of Income. Due to the lack of readily determinable fair value for this investment, over which the Company does not have significant influence, the Company will continue to value the investment under the measurement alternative. During the quarter ended September 30, 2022, the Company made investments in two private companies. The Company invested $3,000 in a digital platform that offers financial planning and portfolio management tools to retail and accredited investors. The Company invested $4,000 in a cloud-based treasury and liquidity solution for investment management firms. Due to the lack of readily determinable fair values for these investments, over which the Company does not have significant influence, the Company will value the investments under the measurement alternative. During the quarter ended December 31, 2022, the Company made additional investments in three private companies in which it previously invested. The Company invested an additional $1,228 in a cloud-based treasury and liquidity solution for investment management firms. The Company invested an additional $5,061 in a company that provides environmental, social and governance (“ESG”) reporting metrics and analysis to private market firms and private companies. As a result of the transaction, the Company marked its original investment to fair value based upon the transaction price, which resulted in a total unrealized gain of $11,521 during the three months ended December 31, 2022 that is recorded in non-operating (expense) income in the Condensed Consolidated Statements of Income. The Company invested an additional $600 in a technology company that has developed software to automate manual data entry tasks associated with alternative investment reporting. As part of that funding round, a convertible note issued by the investee to the Company converted into additional shares of the investee with a value of $550. Due to the lack of readily determinable fair values for these investments, over which the Company does not have significant influence, the Company will continue to value these investments under the measurement alternative. The Company performs qualitative impairment assessments at each quarter end on its investments recorded under the measurement alternative. As a result of this assessment as of December 31, 2022, the Company determined that a quantitative assessment was required to be performed for one of its investments given a significant decrease in earnings performance and overall economic and market conditions. The assessment indicated that the fair value was less than the carrying value at December 31, 2022. Prior to the impairment recorded, the carrying value of the investment was $74,189. The impairment amount was $43,289 and is included in non-operating (expense) income in the Condensed Consolidated Statements of Income. The fair value was estimated using Level 3 inputs with the significant input as shown in Note 5 below. |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | 5. Fair Value Measurements The following tables summarize the Company’s financial assets and financial liabilities recorded at fair value by fair value hierarchy level: As of December 31, 2022 Level 1 Level 2 Level 3 Total Amortized Cost Financial assets: Other investments $ 6,235 $ — $ 13,954 $ 20,189 $ 10,703 Total financial assets $ 6,235 $ — $ 13,954 $ 20,189 $ 10,703 Financial liabilities: Secured financing (1) — — 13,954 13,954 Total financial liabilities $ — $ — $ 13,954 $ 13,954 As of March 31, 2022 Level 1 Level 2 Level 3 Total Amortized Cost Financial assets: Other investments $ 6,002 $ — $ 13,818 $ 19,820 $ 10,853 Investments held in trust 276,016 — — 276,016 276,000 Total financial assets $ 282,018 $ — $ 13,818 $ 295,836 $ 286,853 Financial liabilities: Warrant liability (2) $ 2,484 $ 399 $ — $ 2,883 Secured financing (1) — — 13,818 13,818 Total financial liabilities $ 2,484 $ 399 $ 13,818 $ 16,701 (1) Secured financing is recorded within other liabilities in the Condensed Consolidated Balance Sheets. (2) Warrant liability is recorded within other liabilities of consolidated variable interests in the Condensed Consolidated Balance Sheets. The following is a reconciliation of other investments for which significant unobservable inputs (Level 3) were used in determining fair value: Private equity funds Direct credit investments Direct equity investments Total other investments Balance as of September 30, 2022 $ 6,252 $ 768 $ 6,060 $ 13,080 Contributions 91 — — 91 Distributions (38) — — (38) Net gain 417 18 386 821 Balance as of December 31, 2022 $ 6,722 $ 786 $ 6,446 $ 13,954 Balance as of March 31, 2022 $ 7,024 $ 774 $ 6,020 $ 13,818 Contributions 114 — — 114 Distributions (893) — — (893) Net gain 477 12 426 915 Balance as of December 31, 2022 $ 6,722 $ 786 $ 6,446 $ 13,954 Private equity funds Direct credit investments Direct equity investments Publicly traded equity security Total other investments Balance as of September 30, 2021 $ 7,159 $ 783 $ 6,068 $ 6,122 $ 20,132 Contributions 204 — — — 204 Distributions (25) — — — (25) Net gain (loss) 1,464 (1) 825 168 2,456 Transfer out — — — (6,290) (6,290) Balance as of December 31, 2021 $ 8,802 $ 782 $ 6,893 $ — $ 16,477 Private equity funds Direct credit investments Direct equity investments Publicly traded equity security Total other investments Balance as of March 31, 2021 $ 6,254 $ 985 $ 6,059 $ — $ 13,298 Contributions 293 — 28 — 321 Distributions (179) (202) — — (381) Net gain (loss) 2,434 (1) 806 (165) 3,074 Transfer in — — — 6,455 6,455 Transfer out — — — (6,290) (6,290) Balance as of December 31, 2021 $ 8,802 $ 782 $ 6,893 $ — $ 16,477 The valuation methodologies, significant unobservable inputs, range of inputs and the weighted average input determined based upon relative fair value of the investments used in recurring Level 3 fair value measurements of financial assets were as follows, as of December 31, 2022: Significant Fair Valuation Unobservable Weighted Value Methodology Inputs Range Average Other investments: Private equity funds $ 6,722 Adjusted net asset value Selected market return 2.3% - 6.3% 3.2% Direct credit investments $ 786 Discounted cash flow Market yield 12.9% - 12.9% 12.9% Direct equity investments $ 6,446 Market approach EBITDA multiple 8.25 - 14.25x 11.61x Market approach Equity multiple 1.8x 1.8x The valuation methodologies, significant unobservable inputs, range of inputs and the weighted average input determined based upon relative fair value of the investments used in non-recurring Level 3 fair value measurements of financial assets were as follows, as of December 31, 2022: Significant Fair Valuation Unobservable Weighted Value Methodology Inputs Range Average Investment valued under the measurement alternative $ 30,900 Market approach Revenue Multiple 3.5x 3.5x For the significant unobservable inputs listed in the tables above: (1) a significant increase or decrease in the selected market return would result in a significantly higher or lower fair value measurement, respectively; (2) a significant increase or decrease in the market yield would result in a significantly lower or higher fair value measurement, respectively; and (3) a significant increase or decrease in the selected multiple would result in a significantly higher or lower fair value measurement, respectively. |
Acquisitions
Acquisitions | 9 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisitions | 6. Acquisitions On April 1, 2021, the Company acquired substantially all the assets of 361 Capital, LLC for a total aggregate cash amount of $13,096, of which $10,096 was paid on the closing date of the acquisition. The remaining $3,000 will be paid in two equal installments on the first and second anniversaries of the closing. On April 1, 2022, the Company paid the first of the two equal installments. The purchase price based upon the fair value of consideration transferred at the date of acquisition is $12,946. The Company recorded $7,145 of definite lived intangible assets related primarily to the acquired investment management contracts, which will be amortized over seven years, and $5,623 of goodwill, which are both recorded in other assets in the Condensed Consolidated Balance Sheets. The remaining assets acquired and liabilities assumed are not material to the condensed consolidated financial statements. Revenue and net income attributable to the acquisition of 361 Capital, LLC were not material for the three and nine months ended December 31, 2022 and 2021, and therefore, pro forma information related to this acquisition is not presented. In December 2022, the Company finalized the transfer of the advisory arrangement to a third party for an agreed upon percentage of the respective funds’ management fees over two calendar years. The Company recognized a gain of $2,771 on the sale of the advisory agreements that is recorded in non-operating (expense) income in the Condensed Consolidated Statements of Income. |
Variable Interest Entities
Variable Interest Entities | 9 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Variable Interest Entities | 7. Variable Interest Entities The Company consolidates certain variable interest entities (“VIEs”) in which it is determined that the Company is the primary beneficiary. Consolidated Variable Interest Entities The Company consolidates general partner entities of certain Partnerships and a Partnership in which it is currently the primary beneficiary, which are not wholly-owned by the Company. The total assets of these consolidated VIEs are $41,498 and $10,036 as of December 31, 2022 and March 31, 2022, respectively. The consolidated VIEs had no liabilities as of December 31, 2022 and March 31, 2022. The assets of the consolidated general partner VIEs represent equity method-investments in direct investment funds and customized separate accounts and the assets of the consolidated Partnership VIE represent cash and direct credit investments. The assets may only be used to settle obligations of the respective consolidated VIEs, if any. In addition, there is no recourse to the Company for the consolidated VIEs’ liabilities, except for certain entities in which there could be a clawback of previously distributed carried interest. The Company previously sponsored and consolidated Hamilton Lane Alliance Holdings I, Inc. (“HLAH”) through HL Alliance Holdings Sponsor LLC, an indirect wholly-owned subsidiary of the Company. On January 15, 2021, HLAH completed an IPO raising total gross proceeds of $276,000, which were placed in a trust and could only be utilized for funding a business combination or the redemption of Class A shares of HLAH. In a private placement concurrent with the IPO, HLAH sold warrants to HL Alliance Holdings Sponsor LLC for gross proceeds of $7,520, which were used by HLAH to pay the offering costs and also to provide working capital. On December 15, 2022, HLAH was liquidated, as it was determined that HLAH would be unable to consummate an initial business combination within the time period required by its governing documents. In connection with the liquidation, HLAH redeemed all of the outstanding shares of Class A common stock, cancelled all of the outstanding public and private warrants and settled all other outstanding liabilities. Nonconsolidated Variable Interest Entities The Company holds variable interests in certain Partnerships that are VIEs, which are not consolidated, as it is determined that the Company is not the primary beneficiary based upon the Company’s equity interest percentage in each of the VIEs. Certain Partnerships are considered VIEs because limited partners lack the ability to remove the general partner or dissolve the entity without cause, by simple majority vote (i.e. do not have substantive “kick out” or “liquidation” rights). The Company’s involvement with such entities is in the form of direct equity interests in, and fee arrangements with, the Partnerships in which it also serves as the general partner or managing member. In the Company’s role as general partner or managing member, it generally considers itself the sponsor of the applicable Partnership and makes all investment and operating decisions. As of December 31, 2022, the total remaining unfunded commitments from the Company’s general partner entities to the nonconsolidated VIEs was $140,691. Investor commitments are the primary source of financing for the nonconsolidated VIEs. The maximum exposure to loss represents the potential loss of assets recognized by the Company relating to these nonconsolidated entities. The Company believes that its maximum exposure to loss is limited because it establishes separate limited partnerships or limited liability companies to serve as the general partner or managing member of the Partnerships. The carrying value of assets and liabilities recognized in the Condensed Consolidated Balance Sheet related to the Company’s interests in these nonconsolidated VIEs and the Company’s maximum exposure to loss relating to non-consolidated VIEs were as follows: December 31, March 31, 2022 2022 Investments $ 190,735 $ 191,378 Fees receivable 16,418 9,754 Due from related parties 1,901 778 Total VIE Assets 209,054 201,910 Less: Non-controlling interests (1,534) (1,873) Maximum exposure to loss $ 207,520 $ 200,037 |
Debt
Debt | 9 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | 8. Debt The Company’s debt consisted of the following: As of December 31, 2022 As of March 31, 2022 Principal Outstanding Carrying Value Interest Rate Principal Outstanding Carrying Value Interest Rate Term Loan $ 100,000 $ 99,578 6.25 % $ 71,754 $ 71,574 2.25 % 2020 Multi-Draw Facility 100,000 99,548 3.50 % 100,000 99,752 3.50 % Total Debt $ 200,000 $ 199,126 $ 171,754 $ 171,326 In October 2022, the Company modified its existing credit facility with its lender. The modifications took the form of a new 2022 Multi-Draw Term Loan and Security Agreement, as well as amendments to the existing Revolving Loan and Security Agreement, Term Loan and Security Agreement and 2020 Multi-Draw Term Loan and Security Agreement (collectively, the “Loan Agreements”). |
Equity
Equity | 9 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Equity | 9. Equity The following table shows a rollforward of the Company’s common stock outstanding since March 31, 2022: Class A Common Stock Class B Common Stock March 31, 2022 37,280,697 16,033,359 Forfeitures (5,899) (79,677) Shares repurchased for employee tax withholdings (2,311) — Awards granted 569,442 — Shares issued pursuant to Employee Share Purchase Plan 26,762 — December 31, 2022 37,868,691 15,953,682 |
Equity-Based Compensation
Equity-Based Compensation | 9 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Equity-Based Compensation | 10. Equity Based Compensation Restricted Stock Awards A summary of restricted stock activity for the nine months ended December 31, 2022 is presented below: Total Weighted- March 31, 2022 281,307 $ 67.50 Granted 41,160 $ 66.97 Vested (11,485) $ 77.38 Forfeited (5,899) $ 70.15 December 31, 2022 305,083 $ 67.00 As of December 31, 2022, total unrecognized compensation expense related to restricted stock was $14,950. Performance Awards The Company granted performance stock awards to certain employees that are subject to both a market-based vesting and a service-based vesting condition (“Performance Awards”). The Performance Awards will vest based upon (i) the market price of HLI Class A common stock achieving certain price thresholds from $150 per share to $230 per share and (ii) continued employment through the date the price target is met (with a minimum of five years of service required after the grant date for vesting). If the price target is met prior to the fifth anniversary of the grant date, the vesting date will be the fifth anniversary of the grant date. Holders of the Performance Awards do not participate in dividends until such awards have met both their market-based and service-based vesting requirements. Due to the existence of the service requirement, the vesting period for these awards will vary with each respective tranche as the employees must be employed with the Company at the point in which the market requirement is met with a minimum of five years of service required after the grant date for vesting. As such, compensation expense will be recognized ratably for each vesting tranche from the grant date to the end for the employee’s service period. The fair value of the awards granted are based on a Monte-Carlo simulation valuation model. A summary of Performance Award activity for the nine months ended December 31, 2022 is presented below: Total Weighted- March 31, 2022 — $ — Granted 528,282 $ 29.79 Vested — $ — Forfeited — $ — December 31, 2022 528,282 $ 29.79 Below is a summary of the grant date fair value based on the Monte Carlo simulation valuation model and the significant assumptions used to estimate the grant date fair value of the Performance Awards granted September 16, 2022: Grant Date Fair Value $ 29.79 Closing share price as of grant date $ 69.67 Risk Free Rate 3.6% Volatility 37.0% Dividend Yield 2.3% As of December 31, 2022, total estimated unrecognized expense related to the unvested Performance Awards was $14,815, and none of the Performance Awards have met their market price based vesting condition. |
Compensation and Benefits
Compensation and Benefits | 9 Months Ended |
Dec. 31, 2022 | |
Compensation Related Costs [Abstract] | |
Compensation and Benefits | 11. Compensation and Benefits The Company has recorded the following amounts related to compensation and benefits: Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Base compensation and benefits $ 35,473 $ 29,340 $ 116,549 $ 79,014 Incentive fee compensation 7,368 2,953 34,870 9,308 Equity-based compensation 2,835 1,711 6,816 5,706 Total compensation and benefits $ 45,676 $ 34,004 $ 158,235 $ 94,028 |
Income Tax
Income Tax | 9 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Tax | 12. Income Tax The Company’s effective tax rate used for interim periods is based on an estimated annual effective tax rate including the tax effect of items required to be recorded discretely in the interim period in which those items occur. The effective tax rate is dependent on many factors, including the estimated amount of income subject to income tax; therefore, the effective tax rate can vary from period to period. The Company evaluates the realizability of its deferred tax asset on a quarterly basis and adjusts the valuation allowance when it is more likely than not that all or a portion of the deferred tax asset may not be realized. The Company’s effective tax rate was 35.0% and 22.2% for the three and nine months ended December 31, 2022, respectively, and 12.6% and 15.2% for the three and nine months ended December 31, 2021, respectively. The effective tax rates were different from the statutory tax rates due to the portion of income allocated to non-controlling interests, valuation allowance recorded against deferred tax assets and discrete tax adjustments recorded in the periods. As of December 31, 2022, the Company had no unrecognized tax positions and believes there will be no changes to uncertain tax positions within the next 12 months. |
Earnings per Share
Earnings per Share | 9 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings per Share | 13. Earnings per Share Shares of the Company’s Class B common stock do not share in the earnings or losses attributable to HLI, and, therefore, are not participating securities. As a result, a separate presentation of basic and diluted earnings per share of Class B common stock under the two-class method has not been included. Shares of the Company’s Class B common stock are, however, considered potentially dilutive to the Class A common stock because the Class B units to which the Class B common stock corresponds are exchangeable for shares of Class A common stock on a one-for-one basis, at which time the share of Class B common stock is surrendered in exchange for a payment of its par value. The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted earnings per share of Class A common stock: Three Months Ended Three Months Ended Net income attributable to Class A Stockholders Weighted-Average Shares Per share amount Net income attributable to Class A Stockholders Weighted-Average Shares Per share amount Net income attributable to HLI $ 9,669 $ 51,849 Impact of changes in carrying amount of redeemable NCI 2,095 1,308 Basic EPS of Class A common stock $ 11,764 37,025,416 $ 0.32 $ 53,157 36,902,741 $ 1.44 Adjustment to net income: Assumed vesting of employee awards 5 66 Assumed conversion of Class B and Class C Units 5,058 21,946 Effect of dilutive securities: Assumed vesting of employee awards 68,129 165,569 Assumed conversion of Class B and Class C Units 16,675,834 16,675,834 Diluted EPS of Class A common stock $ 16,827 53,769,379 $ 0.31 $ 75,169 53,744,144 $ 1.40 Nine Months Ended Nine Months Ended Net income attributable to Class A Stockholders Weighted-Average Shares Per share amount Net income attributable to Class A Stockholders Weighted-Average Shares Per share amount Net income attributable to HLI $ 78,034 $ 132,161 Impact of changes in carrying amount of redeemable NCI 3,809 358 Basic EPS of Class A common stock $ 81,843 37,004,657 $ 2.21 $ 132,519 36,375,797 $ 3.64 Adjustment to net income: Assumed vesting of employee awards 34 156 Assumed conversion of Class B and Class C Units 35,968 60,083 Effect of dilutive securities: Assumed vesting of employee awards 53,030 138,902 Assumed conversion of Class B and Class C Units 16,675,834 17,192,702 Diluted EPS of Class A common stock $ 117,845 53,733,521 $ 2.19 $ 192,758 53,707,401 $ 3.59 The adjustments to net income for dilutive securities are based upon the additional income that would be allocated to HLI for the change in its ownership percentage due to the dilutive securities and adjusted for the incremental income tax expense related to the additional allocated income. Net income (loss) recorded by HLI on a standalone basis will determine if the Class B and Class C units are dilutive or antidilutive in each respective period. The calculation of diluted earnings per share excludes 528,282 Performance Awards for the three and nine months ended December 31, 2022 as the market condition was not achieved as of December 31, 2022. |
Related-Party Transactions
Related-Party Transactions | 9 Months Ended |
Dec. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related-Party Transactions | 14. Related Party Transactions The Company considers its employees, directors, and equity method investments to be related parties. Revenue and Receivables The Company has investment management agreements with various specialized funds and customized separate accounts that it manages. The Company earned management and advisory fees from Partnerships of $70,929 and $198,973 for the three and nine months ended December 31, 2022, respectively, and $53,701 and $150,955 for the three and nine months ended December 31, 2021, respectively. The Company earned incentive fees from Partnerships of $28,652 and $137,545 for the three and nine months ended December 31, 2022, respectively, and $10,335 and $34,669 for the three and nine months ended December 31, 2021, respectively. Fees receivable from the Partnerships were $35,263 and $27,728 as of December 31, 2022 and March 31, 2022, respectively, and are included in fees receivable in the Condensed Consolidated Balance Sheets. |
Supplemental Cash Flow Informat
Supplemental Cash Flow Information | 9 Months Ended |
Dec. 31, 2022 | |
Supplemental Cash Flow Information [Abstract] | |
Supplemental Cash Flow Information | 15. Supplemental Cash Flow Nine Months Ended December 31, 2022 2021 Establishment of lease liability in exchange for right of use asset $ 5,401 $ 7,950 Non-cash investing activities: Establishment of receivable for intangible assets sold $ 6,776 $ — Non-cash financing activities: Dividends declared but not paid $ 14,810 $ 12,916 Member distributions declared but not paid $ 19,161 $ 11,769 Establishment of net deferred tax assets related to offerings $ — $ 19,783 |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 16. Commitments and Contigencies Litigation In the ordinary course of business, the Company may be subject to various legal, regulatory, and/or administrative proceedings from time to time. Although there can be no assurance of the outcome of such proceedings, in the opinion of management, the Company does not believe it is probable that any pending or, to its knowledge, threatened legal proceeding or claim would individually or in the aggregate materially affect its condensed consolidated financial statements. Incentive Fees The Partnerships have allocated carried interest still subject to contingencies and did not meet the Company’s criteria for revenue recognition in the amounts of $952,188 and $1,191,066, net of amounts attributable to non-controlling interests, at December 31, 2022 and March 31, 2022, respectively. If the Company ultimately receives the unrecognized carried interest, a total of $238,047 and $297,766 as of December 31, 2022 and March 31, 2022, respectively, would potentially be payable to certain employees and third parties pursuant to compensation arrangements related to carried interest profit-sharing plans. Such amounts have not been recorded in the Condensed Consolidated Balance Sheets or Condensed Consolidated Statements of Income as the payment is not yet probable. Commitments The Company serves as the investment manager of the Partnerships. The general partner or managing member of each Partnership is generally a separate subsidiary of the Company and has agreed to invest funds on the same basis as the limited partners in most instances. The Company’s aggregate unfunded commitment to the Partnerships was $212,895 and $186,164 as of December 31, 2022 and March 31, 2022, respectively. The Company has an unrealized net gain on its investments valued under the measurement alternative of $29,004 as of December 31, 2022, of which up to 15% may be paid as a discretionary bonus as those gains are realized. Leases The Company’s leases consist primarily of operating leases for office space and office equipment in various locations around the world. Some leases have the option to extend for an additional term or terminate early. Short-term lease costs are not material . The following table shows lease costs and other supplemental information related to the Company’s operating leases: Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Operating lease costs $ 2,095 $ 2,011 $ 6,199 $ 7,610 Variable lease costs $ 395 $ 416 $ 1,067 $ 980 Cash paid for amounts included in the measurement of operating lease liabilities $ 1,997 $ 1,657 $ 5,858 $ 4,794 Weighted average remaining lease term (in years) 14.0 14.7 Weighted average discount rate 3.3 % 3.2 % As of December 31, 2022, the maturities of operating lease liabilities were as follows: Remainder of FY2023 $ 2,092 FY2024 7,645 FY2025 7,233 FY2026 6,623 FY2027 6,623 Thereafter 70,210 Total lease payments 100,426 Less: imputed interest (20,877) Total operating lease liabilities $ 79,549 |
Subsequent Events
Subsequent Events | 9 Months Ended |
Dec. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | 17. Subsequent Events On February 7, 2023, the Company declared a quarterly dividend of $0.40 per share of Class A common stock to record holders at the close of business on March 15, 2023. The payment date will be April 6, 2023. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of PresentationThe accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. Management believes it has made all necessary adjustments (which consisted of only normal recurring items) so that the condensed consolidated financial statements are presented fairly and that estimates made in preparing the condensed consolidated financial statements are reasonable and prudent. Results of operations for the three and nine months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the year ending March 31, 2023. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in HLI’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022. |
Accounting for Differing Fiscal Periods | Accounting for Differing Fiscal Periods The Partnerships primarily have a fiscal year end as of December 31, and the Company accounts for its investments in the Partnerships using a three-month lag due to the timing of financial information received from the investments held by the Partnerships. The Partnerships primarily invest in private equity funds, which generally require at least 90 days following the calendar year end to present audited financial statements. The Company records its share of capital contributions to and distributions from the Partnerships in investments in the Condensed Consolidated Balance Sheets during the three-month lag period. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company utilizes a hierarchy that prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach, and cost approach). The levels of the hierarchy are described below: • Level 1: Values are determined using quoted market prices for identical financial instruments in an active market. • Level 2: Values are determined using quoted prices for similar financial instruments and valuation models whose inputs are observable. • Level 3: V alues are determined using pricing models that use significant inputs that are primarily unobservable, discounted cash flow methodologies or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In June 2022, the Financial Accounting Standards Board issued Accounting Standard Update ("ASU") 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this update clarify the guidance in Topic 820 when measuring the fair value of an equity security subject to contractual sale restrictions and introduce new disclosure requirements related to such equity securities. The amendments are effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its condensed consolidated financial statements. |
Reclassifications | Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. |
Revenue (Tables)
Revenue (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table presents revenues disaggregated by product offering, which aligns with the identified performance obligations and the basis for calculating each amount: Three Months Ended Nine Months Ended December 31, Management and advisory fees 2022 2021 2022 2021 Specialized funds $ 53,299 $ 38,233 $ 144,099 $ 107,935 Customized separate accounts 29,571 25,982 87,329 75,416 Advisory 6,613 6,119 19,073 18,781 Reporting and other 6,720 5,992 19,170 16,983 Distribution management 596 3,170 1,863 9,313 Fund reimbursement revenue 556 340 4,648 1,225 Total management and advisory fees $ 97,355 $ 79,836 $ 276,182 $ 229,653 Three Months Ended Nine Months Ended December 31, Incentive fees 2022 2021 2022 2021 Specialized funds $ 8,679 $ 6,765 $ 102,815 $ 23,903 Customized separate accounts 15,396 3,725 30,020 10,314 Consolidated variable interest related: Specialized funds 5,644 1,378 6,948 3,149 Total incentive fees $ 29,719 $ 11,868 $ 139,783 $ 37,366 |
Investments (Tables)
Investments (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Schedule of Investments | Investments consist of the following: December 31, March 31, 2022 2022 Equity method investments in Partnerships $ 328,311 $ 326,296 Other equity method investments — 1,573 Other investments 20,189 19,820 Investments valued under the measurement alternative 165,832 156,100 Total Investments $ 514,332 $ 503,789 |
Fair Value Measurement (Tables)
Fair Value Measurement (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Summary of Financial Assets and Liabilities | The following tables summarize the Company’s financial assets and financial liabilities recorded at fair value by fair value hierarchy level: As of December 31, 2022 Level 1 Level 2 Level 3 Total Amortized Cost Financial assets: Other investments $ 6,235 $ — $ 13,954 $ 20,189 $ 10,703 Total financial assets $ 6,235 $ — $ 13,954 $ 20,189 $ 10,703 Financial liabilities: Secured financing (1) — — 13,954 13,954 Total financial liabilities $ — $ — $ 13,954 $ 13,954 As of March 31, 2022 Level 1 Level 2 Level 3 Total Amortized Cost Financial assets: Other investments $ 6,002 $ — $ 13,818 $ 19,820 $ 10,853 Investments held in trust 276,016 — — 276,016 276,000 Total financial assets $ 282,018 $ — $ 13,818 $ 295,836 $ 286,853 Financial liabilities: Warrant liability (2) $ 2,484 $ 399 $ — $ 2,883 Secured financing (1) — — 13,818 13,818 Total financial liabilities $ 2,484 $ 399 $ 13,818 $ 16,701 (1) Secured financing is recorded within other liabilities in the Condensed Consolidated Balance Sheets. (2) Warrant liability is recorded within other liabilities of consolidated variable interests in the Condensed Consolidated Balance Sheets. |
Reconciliation of Other Investments | The following is a reconciliation of other investments for which significant unobservable inputs (Level 3) were used in determining fair value: Private equity funds Direct credit investments Direct equity investments Total other investments Balance as of September 30, 2022 $ 6,252 $ 768 $ 6,060 $ 13,080 Contributions 91 — — 91 Distributions (38) — — (38) Net gain 417 18 386 821 Balance as of December 31, 2022 $ 6,722 $ 786 $ 6,446 $ 13,954 Balance as of March 31, 2022 $ 7,024 $ 774 $ 6,020 $ 13,818 Contributions 114 — — 114 Distributions (893) — — (893) Net gain 477 12 426 915 Balance as of December 31, 2022 $ 6,722 $ 786 $ 6,446 $ 13,954 Private equity funds Direct credit investments Direct equity investments Publicly traded equity security Total other investments Balance as of September 30, 2021 $ 7,159 $ 783 $ 6,068 $ 6,122 $ 20,132 Contributions 204 — — — 204 Distributions (25) — — — (25) Net gain (loss) 1,464 (1) 825 168 2,456 Transfer out — — — (6,290) (6,290) Balance as of December 31, 2021 $ 8,802 $ 782 $ 6,893 $ — $ 16,477 Private equity funds Direct credit investments Direct equity investments Publicly traded equity security Total other investments Balance as of March 31, 2021 $ 6,254 $ 985 $ 6,059 $ — $ 13,298 Contributions 293 — 28 — 321 Distributions (179) (202) — — (381) Net gain (loss) 2,434 (1) 806 (165) 3,074 Transfer in — — — 6,455 6,455 Transfer out — — — (6,290) (6,290) Balance as of December 31, 2021 $ 8,802 $ 782 $ 6,893 $ — $ 16,477 |
Schedule of Assumptions Used | The valuation methodologies, significant unobservable inputs, range of inputs and the weighted average input determined based upon relative fair value of the investments used in recurring Level 3 fair value measurements of financial assets were as follows, as of December 31, 2022: Significant Fair Valuation Unobservable Weighted Value Methodology Inputs Range Average Other investments: Private equity funds $ 6,722 Adjusted net asset value Selected market return 2.3% - 6.3% 3.2% Direct credit investments $ 786 Discounted cash flow Market yield 12.9% - 12.9% 12.9% Direct equity investments $ 6,446 Market approach EBITDA multiple 8.25 - 14.25x 11.61x Market approach Equity multiple 1.8x 1.8x The valuation methodologies, significant unobservable inputs, range of inputs and the weighted average input determined based upon relative fair value of the investments used in non-recurring Level 3 fair value measurements of financial assets were as follows, as of December 31, 2022: Significant Fair Valuation Unobservable Weighted Value Methodology Inputs Range Average Investment valued under the measurement alternative $ 30,900 Market approach Revenue Multiple 3.5x 3.5x |
Variable Interest Entities (Tab
Variable Interest Entities (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Variable Interest Entities | The carrying value of assets and liabilities recognized in the Condensed Consolidated Balance Sheet related to the Company’s interests in these nonconsolidated VIEs and the Company’s maximum exposure to loss relating to non-consolidated VIEs were as follows: December 31, March 31, 2022 2022 Investments $ 190,735 $ 191,378 Fees receivable 16,418 9,754 Due from related parties 1,901 778 Total VIE Assets 209,054 201,910 Less: Non-controlling interests (1,534) (1,873) Maximum exposure to loss $ 207,520 $ 200,037 |
Debt (Tables)
Debt (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of Debt | The Company’s debt consisted of the following: As of December 31, 2022 As of March 31, 2022 Principal Outstanding Carrying Value Interest Rate Principal Outstanding Carrying Value Interest Rate Term Loan $ 100,000 $ 99,578 6.25 % $ 71,754 $ 71,574 2.25 % 2020 Multi-Draw Facility 100,000 99,548 3.50 % 100,000 99,752 3.50 % Total Debt $ 200,000 $ 199,126 $ 171,754 $ 171,326 |
Equity (Tables)
Equity (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Rollforward of Common Stock | The following table shows a rollforward of the Company’s common stock outstanding since March 31, 2022: Class A Common Stock Class B Common Stock March 31, 2022 37,280,697 16,033,359 Forfeitures (5,899) (79,677) Shares repurchased for employee tax withholdings (2,311) — Awards granted 569,442 — Shares issued pursuant to Employee Share Purchase Plan 26,762 — December 31, 2022 37,868,691 15,953,682 |
Equity-Based Compensation (Tabl
Equity-Based Compensation (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Restricted Stock Activity | A summary of restricted stock activity for the nine months ended December 31, 2022 is presented below: Total Weighted- March 31, 2022 281,307 $ 67.50 Granted 41,160 $ 66.97 Vested (11,485) $ 77.38 Forfeited (5,899) $ 70.15 December 31, 2022 305,083 $ 67.00 |
Schedule of Performance Units Activity | A summary of Performance Award activity for the nine months ended December 31, 2022 is presented below: Total Weighted- March 31, 2022 — $ — Granted 528,282 $ 29.79 Vested — $ — Forfeited — $ — December 31, 2022 528,282 $ 29.79 |
Schedule of Valuation Assumptions | Below is a summary of the grant date fair value based on the Monte Carlo simulation valuation model and the significant assumptions used to estimate the grant date fair value of the Performance Awards granted September 16, 2022: Grant Date Fair Value $ 29.79 Closing share price as of grant date $ 69.67 Risk Free Rate 3.6% Volatility 37.0% Dividend Yield 2.3% |
Compensation and Benefits (Tabl
Compensation and Benefits (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Compensation Related Costs [Abstract] | |
Schedule of Compensation and Benefits | The Company has recorded the following amounts related to compensation and benefits: Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Base compensation and benefits $ 35,473 $ 29,340 $ 116,549 $ 79,014 Incentive fee compensation 7,368 2,953 34,870 9,308 Equity-based compensation 2,835 1,711 6,816 5,706 Total compensation and benefits $ 45,676 $ 34,004 $ 158,235 $ 94,028 |
Earnings per Share (Tables)
Earnings per Share (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted earnings per share of Class A common stock: Three Months Ended Three Months Ended Net income attributable to Class A Stockholders Weighted-Average Shares Per share amount Net income attributable to Class A Stockholders Weighted-Average Shares Per share amount Net income attributable to HLI $ 9,669 $ 51,849 Impact of changes in carrying amount of redeemable NCI 2,095 1,308 Basic EPS of Class A common stock $ 11,764 37,025,416 $ 0.32 $ 53,157 36,902,741 $ 1.44 Adjustment to net income: Assumed vesting of employee awards 5 66 Assumed conversion of Class B and Class C Units 5,058 21,946 Effect of dilutive securities: Assumed vesting of employee awards 68,129 165,569 Assumed conversion of Class B and Class C Units 16,675,834 16,675,834 Diluted EPS of Class A common stock $ 16,827 53,769,379 $ 0.31 $ 75,169 53,744,144 $ 1.40 Nine Months Ended Nine Months Ended Net income attributable to Class A Stockholders Weighted-Average Shares Per share amount Net income attributable to Class A Stockholders Weighted-Average Shares Per share amount Net income attributable to HLI $ 78,034 $ 132,161 Impact of changes in carrying amount of redeemable NCI 3,809 358 Basic EPS of Class A common stock $ 81,843 37,004,657 $ 2.21 $ 132,519 36,375,797 $ 3.64 Adjustment to net income: Assumed vesting of employee awards 34 156 Assumed conversion of Class B and Class C Units 35,968 60,083 Effect of dilutive securities: Assumed vesting of employee awards 53,030 138,902 Assumed conversion of Class B and Class C Units 16,675,834 17,192,702 Diluted EPS of Class A common stock $ 117,845 53,733,521 $ 2.19 $ 192,758 53,707,401 $ 3.59 |
Supplemental Cash Flow Inform_2
Supplemental Cash Flow Information (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Supplemental Cash Flow Information [Abstract] | |
Schedule of Supplemental Cash Flow Disclosures | Nine Months Ended December 31, 2022 2021 Establishment of lease liability in exchange for right of use asset $ 5,401 $ 7,950 Non-cash investing activities: Establishment of receivable for intangible assets sold $ 6,776 $ — Non-cash financing activities: Dividends declared but not paid $ 14,810 $ 12,916 Member distributions declared but not paid $ 19,161 $ 11,769 Establishment of net deferred tax assets related to offerings $ — $ 19,783 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Lease Cost, Cash Flows, and Other Supplemental Cash Flow Information Regarding Leases | The following table shows lease costs and other supplemental information related to the Company’s operating leases: Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Operating lease costs $ 2,095 $ 2,011 $ 6,199 $ 7,610 Variable lease costs $ 395 $ 416 $ 1,067 $ 980 Cash paid for amounts included in the measurement of operating lease liabilities $ 1,997 $ 1,657 $ 5,858 $ 4,794 Weighted average remaining lease term (in years) 14.0 14.7 Weighted average discount rate 3.3 % 3.2 % |
Maturity of Operating Lease Liabilities | As of December 31, 2022, the maturities of operating lease liabilities were as follows: Remainder of FY2023 $ 2,092 FY2024 7,645 FY2025 7,233 FY2026 6,623 FY2027 6,623 Thereafter 70,210 Total lease payments 100,426 Less: imputed interest (20,877) Total operating lease liabilities $ 79,549 |
Organization - Narrative (Detai
Organization - Narrative (Details) | Dec. 31, 2022 | Mar. 31, 2022 |
HLA | ||
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] | ||
Percent of economic interest held | 69% | 68.90% |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation of Revenue [Line Items] | ||||
Revenues | $ 127,074 | $ 91,704 | $ 415,965 | $ 267,019 |
Management and advisory fees | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 97,355 | 79,836 | 276,182 | 229,653 |
Specialized funds | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 53,299 | 38,233 | 144,099 | 107,935 |
Customized separate accounts | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 29,571 | 25,982 | 87,329 | 75,416 |
Advisory | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 6,613 | 6,119 | 19,073 | 18,781 |
Reporting and other | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 6,720 | 5,992 | 19,170 | 16,983 |
Distribution management | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 596 | 3,170 | 1,863 | 9,313 |
Fund reimbursement revenue | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 556 | 340 | 4,648 | 1,225 |
Incentive fees | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 29,719 | 11,868 | 139,783 | 37,366 |
Incentive fees | Consolidated Entity Excluding Variable Interest Entities (VIE) | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 24,075 | 10,490 | 132,835 | 34,217 |
Incentive fees | Primary Beneficiary | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 5,644 | 1,378 | 6,948 | 3,149 |
Specialized funds | Consolidated Entity Excluding Variable Interest Entities (VIE) | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 8,679 | 6,765 | 102,815 | 23,903 |
Specialized funds | Primary Beneficiary | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 5,644 | 1,378 | 6,948 | 3,149 |
Customized separate accounts | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | $ 15,396 | $ 3,725 | $ 30,020 | $ 10,314 |
Investments - Schedule of Inves
Investments - Schedule of Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Schedule of Equity Method Investments [Line Items] | ||
Other investments | $ 20,189 | $ 19,820 |
Investments valued under the measurement alternative | 165,832 | 156,100 |
Total Investments | 514,332 | 503,789 |
Equity method investments in Partnerships | ||
Schedule of Equity Method Investments [Line Items] | ||
Equity method investments | 328,311 | 326,296 |
Other equity method investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Equity method investments | $ 0 | $ 1,573 |
Investments - Narrative (Detail
Investments - Narrative (Details) $ in Thousands | 3 Months Ended | 9 Months Ended | |||||
Dec. 31, 2022 USD ($) investment | Sep. 30, 2022 USD ($) investment | Jun. 30, 2022 USD ($) investment | Dec. 31, 2021 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Mar. 31, 2022 USD ($) | |
Schedule of Equity Method Investments [Line Items] | |||||||
Proceeds from sale of equity method investments | $ 10,000 | ||||||
Gain on sale of investment | 9,783 | ||||||
Distributions from investments | $ 1,406 | $ 1,406 | $ 12,739 | ||||
Net gain (loss) | 18,578 | 47,774 | |||||
Unrealized gain (loss) on secured borrowings, fair value adjustment | $ 821 | $ (2,288) | 915 | (3,239) | |||
Investments held | investment | 3 | ||||||
Investments valued under the measurement alternative | $ 165,832 | 165,832 | $ 156,100 | ||||
Convertible note converted to equity securities | 550 | 550 | |||||
Impairment of other investment | 43,289 | 0 | |||||
Private equity funds | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments held | investment | 2 | 2 | |||||
Technology Drive Platform | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments valued under the measurement alternative | $ 3,000 | ||||||
Online Financial Services Platform | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments valued under the measurement alternative | 12,000 | ||||||
Individual Investors And Wealth Management Platform | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments valued under the measurement alternative | 5,236 | ||||||
Digital Platform | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments valued under the measurement alternative | $ 3,000 | ||||||
Cloud-based Treasury And Liquidity Solution For Investment Management Firms | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments valued under the measurement alternative | 1,228 | 4,000 | 1,228 | ||||
ESG Reporting Metrics, Private Market Firms And Private Companies | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments valued under the measurement alternative | 5,061 | 5,061 | |||||
Technology Company | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments valued under the measurement alternative | $ 600 | $ 600 | |||||
Equity method investments in Partnerships | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Percent interest in partnerships | 1% | 1% | |||||
Investment, Held As Collateral | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Net gain (loss) | $ 821 | $ 2,288 | $ 915 | $ 3,239 | |||
Investment, Measurement Alternative | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Net gain (loss) | 11,521 | $ 6,687 | |||||
Investments valued under the measurement alternative | $ 74,189 | ||||||
Impairment of other investment | $ 43,289 |
Fair Value Measurements - Asset
Fair Value Measurements - Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Sep. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Mar. 31, 2021 |
Reported Value Measurement | ||||||
Financial assets: | ||||||
Other investments | $ 10,703 | $ 10,853 | ||||
Investments held in trust | 276,000 | |||||
Total financial assets | 10,703 | 286,853 | ||||
Other investments | 20,189 | 19,820 | ||||
Investments held in trust | 276,016 | |||||
Total financial assets | 20,189 | 295,836 | ||||
Financial liabilities: | ||||||
Warrant liability | 2,883 | |||||
Secured financing | 13,954 | 13,818 | ||||
Total financial liabilities | 13,954 | 16,701 | ||||
Level 1 | ||||||
Financial assets: | ||||||
Other investments | 6,235 | 6,002 | ||||
Investments held in trust | 276,016 | |||||
Total financial assets | 6,235 | 282,018 | ||||
Financial liabilities: | ||||||
Warrant liability | 2,484 | |||||
Secured financing | 0 | 0 | ||||
Total financial liabilities | 0 | 2,484 | ||||
Level 2 | ||||||
Financial assets: | ||||||
Other investments | 0 | 0 | ||||
Investments held in trust | 0 | |||||
Total financial assets | 0 | 0 | ||||
Financial liabilities: | ||||||
Warrant liability | 399 | |||||
Secured financing | 0 | 0 | ||||
Total financial liabilities | 0 | 399 | ||||
Level 3 | ||||||
Financial assets: | ||||||
Other investments | 13,954 | $ 13,080 | 13,818 | $ 16,477 | $ 20,132 | $ 13,298 |
Investments held in trust | 0 | |||||
Total financial assets | 13,954 | 13,818 | ||||
Financial liabilities: | ||||||
Warrant liability | 0 | |||||
Secured financing | 13,954 | 13,818 | ||||
Total financial liabilities | $ 13,954 | $ 13,818 |
Fair Value Measurements - Recon
Fair Value Measurements - Reconciliation of Other Investments (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, beginning balance | $ 19,820 | |||
Net gain (loss) | 18,578 | $ 47,774 | ||
Other investments, ending balance | $ 20,189 | 20,189 | ||
Level 3 | ||||
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, beginning balance | 13,080 | $ 20,132 | 13,818 | 13,298 |
Contributions | 91 | 204 | 114 | 321 |
Distributions | (38) | (25) | (893) | (381) |
Net gain (loss) | 821 | 2,456 | 915 | 3,074 |
Transfer out | (6,290) | (6,290) | ||
Transfer in | 6,455 | |||
Other investments, ending balance | 13,954 | 16,477 | 13,954 | 16,477 |
Private equity funds | ||||
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, ending balance | 6,722 | 6,722 | ||
Private equity funds | Level 3 | ||||
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, beginning balance | 6,252 | 7,159 | 7,024 | 6,254 |
Contributions | 91 | 204 | 114 | 293 |
Distributions | (38) | (25) | (893) | (179) |
Net gain (loss) | 417 | 1,464 | 477 | 2,434 |
Transfer out | 0 | 0 | ||
Transfer in | 0 | |||
Other investments, ending balance | 6,722 | 8,802 | 6,722 | 8,802 |
Direct credit investments | ||||
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, ending balance | 786 | 786 | ||
Direct credit investments | Level 3 | ||||
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, beginning balance | 768 | 783 | 774 | 985 |
Contributions | 0 | 0 | 0 | 0 |
Distributions | 0 | 0 | 0 | (202) |
Net gain (loss) | 18 | (1) | 12 | (1) |
Transfer out | 0 | 0 | ||
Transfer in | 0 | |||
Other investments, ending balance | 786 | 782 | 786 | 782 |
Direct equity investments | ||||
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, ending balance | 6,446 | 6,446 | ||
Direct equity investments | Level 3 | ||||
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, beginning balance | 6,060 | 6,068 | 6,020 | 6,059 |
Contributions | 0 | 0 | 0 | 28 |
Distributions | 0 | 0 | 0 | 0 |
Net gain (loss) | 386 | 825 | 426 | 806 |
Transfer out | 0 | 0 | ||
Transfer in | 0 | |||
Other investments, ending balance | $ 6,446 | 6,893 | $ 6,446 | 6,893 |
Publicly traded equity security | Level 3 | ||||
Reconciliation Of Other Investments [Roll Forward] | ||||
Other investments, beginning balance | 6,122 | 0 | ||
Contributions | 0 | 0 | ||
Distributions | 0 | 0 | ||
Net gain (loss) | 168 | (165) | ||
Transfer out | (6,290) | (6,290) | ||
Transfer in | 6,455 | |||
Other investments, ending balance | $ 0 | $ 0 |
Fair Value Measurements - Valua
Fair Value Measurements - Valuation Methodologies (Details) $ in Thousands | Dec. 31, 2022 USD ($) | Mar. 31, 2022 USD ($) |
Schedule of Equity Method Investments [Line Items] | ||
Fair Value | $ 20,189 | $ 19,820 |
Investment valued under the measurement alternative | 30,900 | |
Private equity funds | ||
Schedule of Equity Method Investments [Line Items] | ||
Fair Value | 6,722 | |
Direct credit investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Fair Value | 786 | |
Direct equity investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Fair Value | $ 6,446 | |
Selected market return | Adjusted net asset value | Minimum | Private equity funds | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 0.023 | |
Selected market return | Adjusted net asset value | Maximum | Private equity funds | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 0.063 | |
Selected market return | Adjusted net asset value | Weighted Average | Private equity funds | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 0.032 | |
Market yield | Discounted cash flow | Minimum | Direct credit investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 0.129 | |
Market yield | Discounted cash flow | Maximum | Direct credit investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 0.129 | |
Market yield | Discounted cash flow | Weighted Average | Direct credit investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 0.129 | |
EBITDA multiple | Market approach | Minimum | Direct equity investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 8.25 | |
EBITDA multiple | Market approach | Maximum | Direct equity investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 14.25 | |
EBITDA multiple | Market approach | Weighted Average | Direct equity investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 11.61 | |
Equity multiple | Market approach | Weighted Average | Direct equity investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 1.8 | |
Revenue Multiple | Market approach | Weighted Average | ||
Schedule of Equity Method Investments [Line Items] | ||
Range of and weighted-average inputs | 3.5 |
Acquisitions (Details)
Acquisitions (Details) $ in Thousands | 9 Months Ended | 12 Months Ended | |
Apr. 01, 2021 USD ($) installment | Dec. 31, 2022 USD ($) | Apr. 01, 2023 USD ($) | |
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Recognized a gain on the sale of the advisory agreements | $ 2,771 | ||
361 Capital, LLC | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Aggregate purchase price | $ 13,096 | ||
Cash paid for acquisition of business | $ 10,096 | ||
Number of installments | installment | 2 | ||
Preliminary purchase price | $ 12,946 | ||
Goodwill | 5,623 | ||
Scenario, Forecast | 361 Capital, LLC | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Cash paid for acquisition of business | $ 3,000 | ||
Customer Contracts | 361 Capital, LLC | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets acquired | $ 7,145 | ||
Finite-lived intangible asset useful life | 7 years |
Variable Interest Entities - Co
Variable Interest Entities - Consolidated VIEs (Details) - USD ($) | Jan. 15, 2021 | Dec. 31, 2022 | Mar. 31, 2022 |
Variable Interest Entity [Line Items] | |||
Total VIE Assets | $ 1,124,361,000 | $ 1,294,946,000 | |
Total liabilities of consolidated VIEs | 594,403,000 | 557,460,000 | |
Remaining unfunded commitments from the limited partners and general partners to the unconsolidated VIE | 140,691,000 | ||
Hamilton Lane Alliance Holdings I, Inc. | |||
Variable Interest Entity [Line Items] | |||
Proceeds from offering | $ 276,000,000 | ||
Primary Beneficiary | |||
Variable Interest Entity [Line Items] | |||
Total liabilities of consolidated VIEs | 0 | 0 | |
Primary Beneficiary | Investments | |||
Variable Interest Entity [Line Items] | |||
Total VIE Assets | $ 41,498,000 | $ 10,036,000 | |
Hamilton Lane Advisors, L.L.C. | Hamilton Lane Alliance Holdings I, Inc. | |||
Variable Interest Entity [Line Items] | |||
Proceeds from offering | $ 7,520,000 |
Variable Interest Entities - Un
Variable Interest Entities - Unconsolidated VIEs (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Variable Interest Entity [Line Items] | ||
Remaining unfunded commitments from the limited partners and general partners to the unconsolidated VIE | $ 140,691 | |
Statement of Financial Position [Abstract] | ||
Investments | 514,332 | $ 503,789 |
Fees receivable | 52,074 | 51,869 |
Due from related parties | 7,784 | 1,872 |
Total assets | 1,124,361 | 1,294,946 |
Not Primary Beneficiary | ||
Statement of Financial Position [Abstract] | ||
Investments | 190,735 | 191,378 |
Fees receivable | 16,418 | 9,754 |
Due from related parties | 1,901 | 778 |
Total assets | 209,054 | 201,910 |
Less: Non-controlling interests | (1,534) | (1,873) |
Maximum exposure to loss | $ 207,520 | $ 200,037 |
Debt (Details)
Debt (Details) - USD ($) | Dec. 31, 2022 | Mar. 31, 2022 |
Debt Instrument [Line Items] | ||
Principal Outstanding | $ 200,000,000 | $ 171,754,000 |
Carrying Value | 199,126,000 | 171,326,000 |
Line of Credit | ||
Debt Instrument [Line Items] | ||
Credit facility, borrowing capacity | 325,000,000 | |
Line of Credit | Term Loan | ||
Debt Instrument [Line Items] | ||
Principal Outstanding | 100,000,000 | 71,754,000 |
Carrying Value | $ 99,578,000 | $ 71,574,000 |
Interest Rate | 6.25% | 2.25% |
Credit facility, borrowing capacity | $ 100,000,000 | |
Line of Credit | 2020 Multi-Draw Facility | ||
Debt Instrument [Line Items] | ||
Principal Outstanding | 100,000,000 | $ 100,000,000 |
Carrying Value | $ 99,548,000 | $ 99,752,000 |
Interest Rate | 3.50% | 3.50% |
Debt, fair value | $ 86,782,000 |
Equity - Shares of Common Stock
Equity - Shares of Common Stock Outstanding (Details) | 9 Months Ended |
Dec. 31, 2022 shares | |
Class A Common Stock | |
Common Stock, Shares Outstanding [Roll Forward] | |
Outstanding, beginning of period (in shares) | 37,280,697 |
Forfeitures (in shares) | (5,899) |
Shares repurchased for employee tax withholdings (in shares) | (2,311) |
Restricted stock granted (in shares) | 569,442 |
Employee Share Purchase Plan share issuance (in shares) | 26,762 |
Outstanding, end of period (in shares) | 37,868,691 |
Class B Common Stock | |
Common Stock, Shares Outstanding [Roll Forward] | |
Outstanding, beginning of period (in shares) | 16,033,359 |
Forfeitures (in shares) | (79,677) |
Shares repurchased for employee tax withholdings (in shares) | 0 |
Restricted stock granted (in shares) | 0 |
Employee Share Purchase Plan share issuance (in shares) | 0 |
Outstanding, end of period (in shares) | 15,953,682 |
Equity-Based Compensation - Sum
Equity-Based Compensation - Summary of Restricted Stock (Details) - $ / shares | 9 Months Ended | |
Sep. 16, 2022 | Dec. 31, 2022 | |
Restricted Stock | ||
Total Unvested | ||
Unvested at beginning of period (in shares) | 281,307 | |
Granted (in shares) | 41,160 | |
Vested (in shares) | (11,485) | |
Forfeited (in shares) | (5,899) | |
Unvested at end of period (in shares) | 305,083 | |
Weighted- Average Grant-Date Fair Value of Award | ||
Unvested at beginning of period (in dollars per share) | $ 67.50 | |
Granted (in dollars per share) | 66.97 | |
Vested (in dollars per share) | 77.38 | |
Forfeited (in dollars per share) | 70.15 | |
Unvested at end of period (in dollars per share) | $ 67 | |
Performance Shares | ||
Total Unvested | ||
Unvested at beginning of period (in shares) | 0 | |
Granted (in shares) | 528,282 | |
Vested (in shares) | 0 | |
Forfeited (in shares) | 0 | |
Unvested at end of period (in shares) | 528,282 | |
Weighted- Average Grant-Date Fair Value of Award | ||
Unvested at beginning of period (in dollars per share) | $ 0 | |
Granted (in dollars per share) | $ 29.79 | 29.79 |
Vested (in dollars per share) | 0 | |
Forfeited (in dollars per share) | 0 | |
Unvested at end of period (in dollars per share) | $ 29.79 |
Equity-Based Compensation - Nar
Equity-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | 9 Months Ended | |
Dec. 31, 2022 | Sep. 16, 2022 | |
Restricted Stock | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Total unrecognized compensation expense | $ 14,950 | |
Performance Shares | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Total unrecognized compensation expense | $ 14,815 | |
Share price (in USD per share) | $ 69.67 | |
Performance Shares | Senior Leadership | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Requisite service period (in years) | 5 years | |
Performance Shares | Senior Leadership | Minimum | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Share price (in USD per share) | $ 150 | |
Performance Shares | Senior Leadership | Maximum | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Share price (in USD per share) | $ 230 |
Equity-Based Compensation - S_2
Equity-Based Compensation - Summary of the Grant Date Fair Value Based on the Monte Carlo simulation Valuation Model (Details) - Performance Shares - $ / shares | 9 Months Ended | |
Sep. 16, 2022 | Dec. 31, 2022 | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Granted (in dollars per share) | $ 29.79 | $ 29.79 |
Closing share price as of valuation date (in USD per share) | $ 69.67 | |
Risk Free Rate | 3.60% | |
Volatility | 37% | |
Dividend Yield | 2.30% |
Compensation and Benefits - Sch
Compensation and Benefits - Schedule of Compensation and Benefits (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Compensation Related Costs [Abstract] | ||||
Base compensation and benefits | $ 35,473 | $ 29,340 | $ 116,549 | $ 79,014 |
Incentive fee compensation | 7,368 | 2,953 | 34,870 | 9,308 |
Equity-based compensation | 2,835 | 1,711 | 6,816 | 5,706 |
Total compensation and benefits | $ 45,676 | $ 34,004 | $ 158,235 | $ 94,028 |
Income Tax (Details)
Income Tax (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||||
Effective tax rate | 35% | 12.60% | 22.20% | 15.20% |
Unrecognized tax positions | $ 0 | $ 0 |
Earnings per Share - Narrative
Earnings per Share - Narrative (Details) | 3 Months Ended | 9 Months Ended |
Dec. 31, 2022 shares | Dec. 31, 2022 shares | |
Performance Shares | ||
Class of Stock [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 528,282 | 528,282 |
Class B Common Stock | ||
Class of Stock [Line Items] | ||
Common stock, conversion ratio | 1 | 1 |
Earnings per Share - Schedule o
Earnings per Share - Schedule of Earnings Per Share - Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Net income attributable to Class A Stockholders | ||||
Net income attributable to HLI | $ 9,669 | $ 51,849 | $ 78,034 | $ 132,161 |
Class A Common Stock | ||||
Net income attributable to Class A Stockholders | ||||
Net income attributable to HLI | 9,669 | 51,849 | 78,034 | 132,161 |
Impact of changes in carrying amount of redeemable NCI | 2,095 | 1,308 | 3,809 | 358 |
Basic EPS of Class A common stock | 11,764 | 53,157 | 81,843 | 132,519 |
Assumed vesting of employee awards | 5 | 66 | 34 | 156 |
Assumed conversion of Class B and Class C Units | 5,058 | 21,946 | 35,968 | 60,083 |
Diluted EPS of Class A common stock | $ 16,827 | $ 75,169 | $ 117,845 | $ 192,758 |
Weighted-Average Shares | ||||
Weighted-average basic EPS of Class A common stock (in shares) | 37,025,416 | 36,902,741 | 37,004,657 | 36,375,797 |
Weighted-average assumed vesting of employee awards (in shares) | 68,129 | 165,569 | 53,030 | 138,902 |
Weighted-average assumed conversion of Class B and Class C units (in shares) | 16,675,834 | 16,675,834 | 16,675,834 | 17,192,702 |
Weighted-average diluted EPS of Class A common stock (in shares) | 53,769,379 | 53,744,144 | 53,733,521 | 53,707,401 |
Per share amount | ||||
Basic EPS of Class A common stock (in dollars per share) | $ 0.32 | $ 1.44 | $ 2.21 | $ 3.64 |
Diluted EPS of Class A common stock (in dollars per share) | $ 0.31 | $ 1.40 | $ 2.19 | $ 3.59 |
Related-Party Transactions - Na
Related-Party Transactions - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2022 | |
Related Party Transaction [Line Items] | |||||
Revenues | $ 127,074 | $ 91,704 | $ 415,965 | $ 267,019 | |
Fees receivable | 52,074 | 52,074 | $ 51,869 | ||
General Partnerships | |||||
Related Party Transaction [Line Items] | |||||
Fees receivable | 35,263 | 35,263 | $ 27,728 | ||
Management and advisory fees | |||||
Related Party Transaction [Line Items] | |||||
Revenues | 97,355 | 79,836 | 276,182 | 229,653 | |
Management and advisory fees | General Partnerships | |||||
Related Party Transaction [Line Items] | |||||
Revenues | 70,929 | 53,701 | 198,973 | 150,955 | |
Incentive fees | |||||
Related Party Transaction [Line Items] | |||||
Revenues | 29,719 | 11,868 | 139,783 | 37,366 | |
Incentive fees | General Partnerships | |||||
Related Party Transaction [Line Items] | |||||
Revenues | $ 28,652 | $ 10,335 | $ 137,545 | $ 34,669 |
Supplemental Cash Flow Inform_3
Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2022 | |
Supplemental Cash Flow Information [Abstract] | |||
Establishment of lease liability in exchange for right of use asset | $ 5,401 | $ 7,950 | |
Establishment of receivable for intangible assets sold | 6,776 | 0 | |
Non-cash financing activities: | |||
Dividends Payable | 14,810 | 12,916 | $ 12,947 |
Member Distribution Declared | 19,161 | 11,769 | |
Establishment of net deferred tax assets related to offerings | $ 0 | $ 19,783 |
Commitments and Contingencies -
Commitments and Contingencies - Incentive Fees (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Commitments and Contingencies Disclosure [Abstract] | ||
Carried interest still subject to contingencies | $ 952,188 | $ 1,191,066 |
Incentive fees, unrecorded estimate | $ 238,047 | $ 297,766 |
Commitments and Contingencies_2
Commitments and Contingencies - Commitments (Details) - USD ($) $ in Thousands | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |||
Other commitment | $ 212,895 | $ 186,164 | |
Loss Contingencies [Line Items] | |||
Other commitment | 212,895 | $ 186,164 | |
Net gain (loss) | 18,578 | $ 47,774 | |
Valued Under Measurement Alternative | |||
Loss Contingencies [Line Items] | |||
Net gain (loss) | $ 29,004 | ||
Maximum | |||
Loss Contingencies [Line Items] | |||
Accrued discretionary bonus | 15% |
Commitments and Contingencies_3
Commitments and Contingencies - Lease Cost (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | ||||
Operating lease costs | $ 2,095 | $ 2,011 | $ 6,199 | $ 7,610 |
Variable lease costs | 395 | 416 | 1,067 | 980 |
Cash paid for amounts included in the measurement of operating lease liabilities | $ 1,997 | $ 1,657 | $ 5,858 | $ 4,794 |
Weighted average remaining lease term (in years) | 14 years | 14 years 8 months 12 days | 14 years | 14 years 8 months 12 days |
Weighted average discount rate | 3.30% | 3.20% | 3.30% | 3.20% |
Commitments and Contingencies_4
Commitments and Contingencies - Operating Lease Maturities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Commitments and Contingencies Disclosure [Abstract] | ||
Remainder of FY2023 | $ 2,092 | |
FY2024 | 7,645 | |
FY2025 | 7,233 | |
FY2026 | 6,623 | |
FY2027 | 6,623 | |
Thereafter | 70,210 | |
Total lease payments | 100,426 | |
Less: imputed interest | (20,877) | |
Total operating lease liabilities | $ 79,549 | $ 82,244 |
Subsequent Events (Details)
Subsequent Events (Details) - Class A Common Stock - $ / shares | 3 Months Ended | 9 Months Ended | |||
Feb. 07, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Subsequent Event [Line Items] | |||||
Dividends declared per share of Class A common stock (in dollars per share) | $ 0.40 | $ 0.35 | $ 1.20 | $ 1.05 | |
Subsequent Event | |||||
Subsequent Event [Line Items] | |||||
Dividends declared per share of Class A common stock (in dollars per share) | $ 0.40 |